Sherbrooke Park Advisers LLC Pacira Bio Sciences, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $436 Billion
- Q3 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 29,342 shares of PCRX stock, worth $581,851. This represents 0.1% of its overall portfolio holdings.
Number of Shares
29,342
Previous 16,337
79.6%
Holding current value
$581,851
Previous $467 Million
5.52%
% of portfolio
0.1%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding PCRX
# of Institutions
264Shares Held
50.6MCall Options Held
429KPut Options Held
391K-
Black Rock Inc. New York, NY8.01MShares$159 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$105 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA4.96MShares$98.4 Million0.18% of portfolio
-
State Street Corp Boston, MA2.01MShares$39.9 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$39.2 Million0.05% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $909M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...